Certains des articles sont en lien ci-dessous
Reference List
1. Abdallah M, Genereau T, Donadieu J, Emile JF, Chazouilleres O, Gaujoux-Viala C et al.: Langerhans' cell histiocytosis of the liver in adults. Clin Res Hepatol Gastroenterol 2011, 35: 475-481.
2. Akkari V, Donadieu J, Piguet C, Bordigoni P, Michel G, Blanche S et al.: Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: experience of the French Langerhans Cell Study Group. Bone Marrow Transplant 2003, 31: 1097-1103.
3. Arico M, Girschikofsky M, Genereau T, Klersy C, McClain K, Grois N et al.: Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer 2003, 39: 2341-2348.
4. Barthez MA, Araujo E, Donadieu J: Langerhans cell histiocytosis and the central nervous system in childhood: evolution and prognostic factors. Results of a collaborative study. J Child Neurol 2000, 15: 150-156.
5. Bernard F, Thomas C, Bertrand Y, Munzer M, Landman PJ, Ouache M et al.: Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction. Eur J Cancer 2005, 41: 2682-2689.
6. Blouin P, Yvert M, Arbion F, Pagnier A, Emile JF, Eitenschenck L et al.: Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA-AraC. Pediatr Blood Cancer 2010, 55: 757-760.
7. Donadieu J, Rolon MA, Pion I, Thomas C, Doz F, Barkaoui M et al.: Incidence of growth hormone deficiency in pediatric-onset Langerhans cell histiocytosis: efficacy and safety of growth hormone treatment. J Clin Endocrinol Metab 2004, 89: 604-609.
8. Donadieu J, Piguet C, Bernard F, Barkaoui M, Ouache M, Bertrand Y et al.: A new clinical score for disease activity in Langerhans cell histiocytosis. Pediatr Blood Cancer 2004, 43: 770-776.
9. Donadieu J: Langerhans cell histiocytosis: portrait of a disease as a rare tumour. Eur J Cancer 2004, 40: 1465-1466.
10. Donadieu J, Rolon MA, Thomas C, Brugieres L, Plantaz D, Francois EJ et al.: Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study. J Pediatr 2004, 144: 344-350.
11. Donadieu J: A single-centre study can improve our knowledge of a rare disease! As exemplified by studies in Langerhans' cell histiocytosis. Acta Paediatr 2005, 94: 1010-1011.
12. Donadieu J, Egeler M, Pritchard J: Langerhans cell histiocytosis: a clinical update. In Histiocytic Disorders of Children and Adults. Edited by Weitzman S, Egeler M. 2005:95-129.
13. Donadieu J, Guyot-Goubin A, Clavel J, Thomas C: [Clinical presentation and epidemiology of childhood Langerhans cell Histiocytosis]
33. Arch Pediatr 2008, 15: 520-522.
14. Emile JF, Peuchmaur M, Fraitag S, Bodemer C, Brousse N: Immunohistochemical detection of granulocyte/macrophage colony-stimulating factor in Langerhans' cell histiocytosis. Histopathology 1993, 23: 327-332.
15. Emile JF, Fraitag S, Leborgne M, De Prost Y, Brousse N: Langerhans' cell histiocytosis cells are activated Langerhans' cells. J Pathol 1994, 174: 71-76.
16. Emile JF, Tartour E, Brugieres L, Donadieu J, Le Deist F, Charnoz I et al.: Detection of GM-CSF in the sera of children with Langerhans' cell histiocytosis. Pediatr Allergy Immunol 1994, 5: 162-163.
17. Emile JF, Fraitag S, Andry P, Leborgne M, Lellouch-Tubiana A, Brousse N: Expression of GM-CSF receptor by Langerhans' cell histiocytosis cells. Virchows Arch 1995, 427: 125-129.
18. Emile JF, Wechsler J, Brousse N, Boulland ML, Cologon R, Fraitag S et al.: Langerhans' cell histiocytosis. Definitive diagnosis with the use of monoclonal antibody O10 on routinely paraffin-embedded samples. Am J Surg Pathol 1995, 19: 636-641.
19. Emile JF, Fraitag S, Leborgne M, De Prost Y, Brousse N: In situ expression of activation markers by Langerhans' cells containing GM-CSF. Adv Exp Med Biol 1995, 378:101-3.: 101-103.
20. Emile JF, Geissmann F, Martin OC, Radford-Weiss I, Lepelletier Y, Heymer B et al.: Langerhans cell deficiency in reticular dysgenesis. Blood 2000, 96: 58-62.
21. Fogg DK, Sibon C, Miled C, Jung S, Aucouturier P, Littman DR et al.: A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006, 311: 83-87.
22. Gadner H, Grois N, Arico M, Broadbent V, Ceci A, Jakobson A et al.: A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 2001, 138: 728-734.
23. Gadner H, Grois N, Potschger U, Minkov M, Arico M, Braier J et al.: Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood 2007.
24. Geissmann F, Thomas C, Emile JF, Micheau M, Canioni D, Cerf-Bensussan N et al.: Digestive tract involvement in Langerhans cell histiocytosis. The French Langerhans Cell Histiocytosis Study Group. J Pediatr 1996, 129: 836-845.
25. Geissmann F, Emile JF, Andry P, Thomas C, Fraitag S, De Prost Y et al.: Lack of expression of E-cadherin is associated with dissemination of Langerhans' cell histiocytosis and poor outcome. J Pathol 1997, 181: 301-304.
26. Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O: Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 1998, 187: 961-966.
27. Geissmann F, Thomas C: Etat des connaissances concernant la présentation clinique, la physiopathologie et le traitement de l'histiocytose langerhansienne (histiocytosis X)]. Arch Pediatr 1999, 6 Suppl 2:414s-416s.: 414s-416s.
28. Geissmann F, Lepelletier Y, Fraitag S, Valladeau J, Bodemer C, Debre M et al.: Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 2001, 97: 1241-1248.
29. Geissmann F, eu-Nosjean MC, Dezutter C, Valladeau J, Kayal S, Leborgne M et al.: Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med 2002, 196: 417-430.
30. Geissmann F, Revy P, Brousse N, Lepelletier Y, Folli C, Durandy A et al.: Retinoids regulate survival and antigen presentation by immature dendritic cells. J Exp Med 2003, 198: 623-634.
31. Geissmann F, Jung S, Littman DR: Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19: 71-82.
32. Geissmann F, Cameron TO, Sidobre S, Manlongat N, Kronenberg M, Briskin MJ et al.: Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 2005, 3: e113.
33. Georget-Bouquinet E, Madhi F, Delacourt C, Billette T, Debray D, Reinert P et al.: [Inaugural trunk dystonia revealing Langerhans cell histiocytosis]. Arch Pediatr 2009, 16: 1021-1023.
34. Grois N, Fahrner B, Arceci RJ, Henter JI, McClain K, Lassmann H et al.: Central nervous system disease in Langerhans cell histiocytosis. J Pediatr 2010, 156: 873-81, 881.
35. Guyot-Goubin A, Donadieu J, Barkaoui M, Bellec S, Thomas C, Clavel J: Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004. Pediatr Blood Cancer 2008, Epub ahead of print.
36. Heritier S, Le MM, Jaubert F, Bigorre M, Gillibert-Yvert M, de Court et al.: Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009. Orphanet J Rare Dis 2010, 5: 3.
37. Idbaih A, Donadieu J, Barthez MA, Geissmann F, Bertrand Y, Hermine O et al.: Retinoic acid therapy in "degenerative-like" neuro-langerhans cell histiocytosis: a prospective pilot study. Pediatr Blood Cancer 2004, 43: 55-58.
38. Jeziorski E, Senechal B, Molina TJ, Devez F, Leruez-Ville M, Morand P et al.: Herpes-virus infection in patients with Langerhans cell histiocytosis: a case-controlled sero-epidemiological study, and in situ analysis
28. PLoS One 2008, 3: e3262.
39. Marchand I, Barkaoui MA, Garel C, Polak M, Donadieu J: Central Diabetes Insipidus as the Inaugural Manifestation of Langerhans Cell Histiocytosis: Natural History and Medical Evaluation of 26 Children and Adolescents. J Clin Endocrinol Metab 2011, 96: E1352-E1360.
40. Martin-Duverneuil N, Idbaih A, Hoang-Xuan K, Donadieu J, Genereau T, Guillevin R et al.: MRI features of neurodegenerative Langerhans cell histiocytosis. Eur Radiol 2006.
41. Minkov M, Steiner M, Potschger U, Arico M, Braier J, Donadieu J et al.: Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry. J Pediatr 2008, 153: 700-5, 705.
42. Ribeiro MJ, Idbaih A, Thomas C, Remy P, Martin-Duverneuil N, Samson Y et al.: (18)F-FDG PET in neurodegenerative Langerhans cell histiocytosis : Results and potential interest for an early diagnosis of the disease. J Neurol 2008.
43. Roger G, Dupre M, Leboulanger N, Godey B, Thomas C, Gandemer V et al.: Cholesteatoma secondary to temporal bone involvement by Langerhans cell histiocytosis: a complication amenable to curative surgery. Otol Neurotol 2009, 30: 190-193.
44. Slacmeulder M, Geissmann F, Lepelletier Y, Fournet JC, Brousse N, Thomas C et al.: No association between Langerhans cell histiocytosis and human herpes virus 8. Med Pediatr Oncol 2002, 39: 187-189.
45. Steiner M, Matthes-Martin S, Attarbaschi A, Minkov M, Grois N, Unger E et al.: Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant 2005, 36: 215-225.
46. Tazi A, Nioche S, Chastre J, Smiejan JM, Hance AJ: Spontaneous release of granulocyte colony-stimulating factor (G-CSF) by alveolar macrophages in the course of bacterial pneumonia and sarcoidosis: endotoxin-dependent and endotoxin-independent G-CSF release by cells recovered by bronchoalveolar lavage. Am J Respir Cell Mol Biol 1991, 4: 140-147.
47. Tazi A, Bonay M, Grandsaigne M, Battesti JP, Hance AJ, Soler P: Surface phenotype of Langerhans cells and lymphocytes in granulomatous lesions from patients with pulmonary histiocytosis X. Am Rev Respir Dis 1993, 147: 1531-1536.
48. Tazi A, Bonay M, Bergeron A, Grandsaigne M, Hance AJ, Soler P: Role of granulocyte-macrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X. Thorax 1996, 51: 611-614.
49. Tazi A, Montcelly L, Bergeron A, Valeyre D, Battesti JP, Hance AJ: Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med 1998, 157: 2007-2010.
50. Tazi A, Moreau J, Bergeron A, Dominique S, Hance AJ, Soler P: Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment. J Immunol 1999, 163: 3511-3515.
51. Tazi A, Soler P, Hance AJ: Adult pulmonary Langerhans' cell histiocytosis. Thorax 2000, 55: 405-416.
52. Tazi A, Jereon T, Hiltermann N, Vassallo R: Adult lung histiocytosis. In Histiocytic Disorders of Children and Adults. Edited by Weitzman S, Egeler M. 2005:187-207.
53. The French Langerhans' Cell Histiocytosis Study Group: A multicentre retrospective survey of Langerhans' cell histiocytosis : 348 cases observed between 1983 and 1993. Arch Dis Child 1996, 75: 17-24.
54. Thomas C, Donnadieu J, Emile JF, Brousse N: Histiocytose langerhansienne. Arch Pediatr 1996, 3: 63-69.
55. Thomas C, Donadieu J: [Langerhans'cell histiocytosis: therapeutic approach]. Arch Pediatr 2008, 15: 529-531.
56. Viollet L, Commare-Nordmann MC, Langlais J, Polak M, Donadieu J: Maladie de Basedow'chez un adolescent avec une histiocytose X. Arch Pediatr 1997, 4: 656-658.
57. Weitzman S, Braier J, Donadieu J, Egeler RM, Grois N, Ladisch S et al.: 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society. Pediatr Blood Cancer 2009, 53: 1271-1276.
Articles du Groupe français avec liens (jusqu'en 2003) :